Shares in China’s CanSino Biologics Inc., one of several companies racing to develop a Covid-19 vaccine, leapt on their first day of trading on a Nasdaq-style tech board in Shanghai. A global scramble is under way to bring Covid-19 vaccines to market. CanSino is working closely with China’s military and is one of the country’s leading contenders, alongside state-owned China National Pharmaceutical Group Co., or Sinopharm, and a smaller private firm, Sinovac Biotech Ltd....

Source: Wall Street Journal August 13, 2020 08:37 UTC